These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 17714780)
1. Expression and function of the calcitonin receptor by myeloma cells in their osteoclast-like activity in vitro. Silvestris F; Cafforio P; De Matteo M; Quatraro C; Dammacco F Leuk Res; 2008 Apr; 32(4):611-23. PubMed ID: 17714780 [TBL] [Abstract][Full Text] [Related]
2. Effects of calcitonin on the function of human osteoclast-like cells formed from CD14-positive monocytes. Yamamoto Y; Yamamoto Y; Udagawa N; Okumura S; Mizoguchi T; Take I; Yamauchi H; Yamauchi H; Noguchi T; Takahashi N Cell Mol Biol (Noisy-le-grand); 2006 May; 52(3):25-31. PubMed ID: 17535751 [TBL] [Abstract][Full Text] [Related]
3. Calcitonin receptor regulation and responsiveness to calcitonin in human osteoclast-like cells prepared in vitro using receptor activator of nuclear factor-kappaB ligand and macrophage colony-stimulating factor. Samura A; Wada S; Suda S; Iitaka M; Katayama S Endocrinology; 2000 Oct; 141(10):3774-82. PubMed ID: 11014233 [TBL] [Abstract][Full Text] [Related]
4. Expression of the calcitonin receptor, calcitonin receptor-like receptor, and receptor activity modifying proteins during osteoclast differentiation. Granholm S; Lundberg P; Lerner UH J Cell Biochem; 2008 Jun; 104(3):920-33. PubMed ID: 18384073 [TBL] [Abstract][Full Text] [Related]
5. Physiological levels of calcitonin regulate the mouse osteoclast calcitonin receptor by a protein kinase Alpha-mediated mechanism. Wada S; Udagawa N; Nagata N; Martin TJ; Findlay DM Endocrinology; 1996 Jan; 137(1):312-20. PubMed ID: 8536630 [TBL] [Abstract][Full Text] [Related]
6. Homologous regulation of the rat C1a calcitonin receptor (CTR) in nonosteoclastic cells is independent of CTR messenger ribonucleic acid changes and cyclic adenosine 3',5'-monophosphate-dependent protein kinase activation. Findlay DM; Houssami S; Christopoulos G; Sexton PM Endocrinology; 1996 Nov; 137(11):4576-85. PubMed ID: 8895320 [TBL] [Abstract][Full Text] [Related]
7. Pulse treatment with the proteasome inhibitor bortezomib inhibits osteoclast resorptive activity in clinically relevant conditions. Boissy P; Andersen TL; Lund T; Kupisiewicz K; Plesner T; Delaissé JM Leuk Res; 2008 Nov; 32(11):1661-8. PubMed ID: 18394701 [TBL] [Abstract][Full Text] [Related]
9. Osteoclast-like cells express receptor activity modifying protein 2: application of laser capture microdissection. Nakamura M; Morimoto S; Yang Q; Hisamatsu T; Hanai N; Nakamura Y; Mori I; Kakudo K J Mol Endocrinol; 2005 Feb; 34(1):257-61. PubMed ID: 15691893 [TBL] [Abstract][Full Text] [Related]
10. beta(3) Integrin subunit mediates the bone-resorbing function exerted by cultured myeloma plasma cells. Tucci M; De Palma R; Lombardi L; Rodolico G; Berrino L; Dammacco F; Silvestris F Cancer Res; 2009 Aug; 69(16):6738-46. PubMed ID: 19654300 [TBL] [Abstract][Full Text] [Related]
11. Homologous regulation of the calcitonin receptor in mouse osteoclast-like cells and human breast cancer T47D cells. Wada S; Martin TJ; Findlay DM Endocrinology; 1995 Jun; 136(6):2611-21. PubMed ID: 7750484 [TBL] [Abstract][Full Text] [Related]
12. Novel cell-surface Ag expressed on rat osteoclasts regulating the function of the calcitonin receptor. Kukita T; Kukita A; Nagata K; Maeda H; Kurisu K; Watanabe T; Iijima T J Immunol; 1994 Dec; 153(11):5265-73. PubMed ID: 7963580 [TBL] [Abstract][Full Text] [Related]
13. CD74 is expressed by multiple myeloma and is a promising target for therapy. Burton JD; Ely S; Reddy PK; Stein R; Gold DV; Cardillo TM; Goldenberg DM Clin Cancer Res; 2004 Oct; 10(19):6606-11. PubMed ID: 15475450 [TBL] [Abstract][Full Text] [Related]
14. Human osteoblast-like cell proliferation induced by calcitonin-related peptides involves PKC activity. Villa I; Dal Fiume C; Maestroni A; Rubinacci A; Ravasi F; Guidobono F Am J Physiol Endocrinol Metab; 2003 Mar; 284(3):E627-33. PubMed ID: 12556355 [TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of two novel isoforms of the human calcitonin receptor. Beaudreuil J; Balasubramanian S; Chenais J; Taboulet J; Frenkian M; Orcel P; Jullienne A; Horne WC; de Vernejoul MC; Cressent M Gene; 2004 Dec; 343(1):143-51. PubMed ID: 15563840 [TBL] [Abstract][Full Text] [Related]
16. Regulation by calcitonin and glucocorticoids of calcitonin receptor gene expression in mouse osteoclasts. Wada S; Udagawa N; Akatsu T; Nagata N; Martin TJ; Findlay DM Endocrinology; 1997 Feb; 138(2):521-9. PubMed ID: 9002981 [TBL] [Abstract][Full Text] [Related]
17. Expression of c-Kit isoforms in multiple myeloma: differences in signaling and drug sensitivity. Montero JC; López-Pérez R; San Miguel JF; Pandiella A Haematologica; 2008 Jun; 93(6):851-9. PubMed ID: 18443272 [TBL] [Abstract][Full Text] [Related]
18. [Effects of calcitonin on osteoclast]. Yamamoto Y; Noguchi T; Takahashi N Clin Calcium; 2005 Mar; 15(3):147-51. PubMed ID: 15741694 [TBL] [Abstract][Full Text] [Related]
19. Regulation of cell growth mediated by the calcitonin receptor. Findlay DM Cell Mol Biol (Noisy-le-grand); 2006 May; 52(3):3-8. PubMed ID: 17535747 [TBL] [Abstract][Full Text] [Related]
20. Calcitonin-induced change in serum calcium levels and its relationship to osteoclast morphology and number of calcitonin receptors. Ikegame M; Ejiri S; Ozawa H Bone; 2004 Jul; 35(1):27-33. PubMed ID: 15207738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]